1. Pink Sheet
  2. >>Advanced Technologies
  3. >>Platform Technologies

Coverage with Evidence Development: A Road to Accelerated Biomarker Adoption

 
• By Sean Tunis

Oncology biomarkers have the potential to significantly improve the quality and efficiency of health care, but their value hinges on whether payers will support the science. Private payer adoption of CMS' "coverage with evidence development" decisions could provide the appropriate regulatory and reimbursement framework.

Sean Tunis, MD, MSc

Sean Tunis is director of the Center for Medical Technology Policy and a principal at Rubix Health. He is the former chief medical officer and director of the Office of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Platform Technologies

More from Advanced Technologies